Melanie Hayden Gephart

4.9/5

29 Patient Ratings

160 Patient Reviews

Melanie Hayden Gephart

Neurosurgeon

Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences

View Professional Summary

Additional Languages Spoken:

Spanish

Insurance Coverage

Online Second Opinion Program

Resources for Referring Physicians

Biography

I am a brain tumor neurosurgeon, treating patients with malignant and benign tumors, including gliomas, brain metastases, meningiomas, and schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cerebrospinal fluid-based biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.

www.GephartLab.com
www.GBMseq.org
https://stan.md/BrainMets
@HaydenGephartMD

View Full Biography

Professional Summary

Education & Certifications

Neurosurgery Residency, Stanford University (2014)
MD, University of California at San Diego (2007)
Board Certification: American Board of Neurological Surgery, Neurosurgery (2018)
- Masters of Advanced Sciences, University of California at San Diego, Clinical Research (2007)
- BS, University of California at San Diego, Neuroscience and Physiology (2001)

Administrative Appointments

Co-Director, Stanford Brain Tumor Center, Stanford University (2018 - Present)
Director, Stanford Brain Metastases Consortium (2018 - Present)

Publications

Cerebellopontine angle cyst compressing the vagus nerve: case report.
Hayden, M. G., Tornabene, S. V., Nguyen, A., Thekdi, A., & Alksne, J. F. (2007). Cerebellopontine angle cyst compressing the vagus nerve: case report. Neurosurgery, 60(6), E1150-?
National trends in vertebral augmentation procedures for the treatment of vertebral compression fractures
Lad, S. P., Patil, C. G., Lad, E. M., Hayden, M. G., & Boakye, M. (2009). National trends in vertebral augmentation procedures for the treatment of vertebral compression fractures. SURGICAL NEUROLOGY, 71(5), 580–85.
Von Hippel-Lindau disease in pregnancy: A brief review
Hayden, M. G., Gephart, R., Kalanithi, P., & Chou, D. (2009). Von Hippel-Lindau disease in pregnancy: A brief review. JOURNAL OF CLINICAL NEUROSCIENCE, 16(5), 611–13.
- Recurring osteoma within a calcium phosphate bone cement cranioplasty: case report.
  Hayden, M. G., Guzman, R., Dulai, M. S., Mobley, B. C., & Edwards, M. S. B. (2009). Recurring osteoma within a calcium phosphate bone cement cranioplasty: case report. Neurosurgery, 64(4), E775–6.
- The evolution of cerebral revascularization surgery
  Hayden, M. G., Lee, M., Guzman, R., & Steinberg, G. K. (2009). The evolution of cerebral revascularization surgery. NEUROSURGICAL FOCUS, 26(5).
- Non-surgical management of hormone-secreting pituitary tumors
  Patil, C. G., Hayden, M., Katznelson, L., & Chang, S. D. (2009). Non-surgical management of hormone-secreting pituitary tumors. JOURNAL OF CLINICAL NEUROSCIENCE, 16(8), 985–93.
- Variations of Endoscopic and Open Repair of Metopic Craniosynostosis
  Keshavarzi, S., Hayden, M. G., Ben-Haim, S., Meltzer, H. S., Cohen, S. R., & Levy, M. L. (2009). Variations of Endoscopic and Open Repair of Metopic Craniosynostosis. JOURNAL OF CRANIOFACIAL SURGERY, 20(5), 1439–1444.
- Maria Auxiliadora Hospital in Lima, Peru as a model for neurosurgical outreach to international charity hospitals
  Hayden, M. G., Hughes, S., Hahn, E. J., Aryan, H. E., Levy, M. L., & Jandial, R. (2011). Maria Auxiliadora Hospital in Lima, Peru as a model for neurosurgical outreach to international charity hospitals. CHILDS NERVOUS SYSTEM, 27(1), 145–48.
- Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
  Mobley, B. C., McKenney, J. K., Bangs, C. D., Callahan, K., Yeom, K. W., Schneppenheim, R., … Vogel, H. (2010). Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. ACTA NEUROPATHOLOGICA, 120(6), 745–53.
- Perioperative posterior reversible encephalopathy syndrome in 2 pediatric neurosurgery patients with brainstem ependymoma Report of 2 cases
  Gephart, M. G. H., Taft, B. P., Giese, A.-K., Guzman, R., & Edwards, M. S. B. (2011). Perioperative posterior reversible encephalopathy syndrome in 2 pediatric neurosurgery patients with brainstem ependymoma Report of 2 cases. JOURNAL OF NEUROSURGERY-PEDIATRICS, 7(3), 235–37.
- Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
  Ma, W., Smith, T., Bogin, V., Zhang, Y., Ozkan, C., Ozkan, M., … Minev, B. (2011). Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy. JOURNAL OF TRANSLATIONAL MEDICINE, 9.
- Multisession Stereotactic Radiosurgery for Vestibular Schwannomas: Single-Institution Experience With 383 Cases
  Hansasuta, A., Choi, C. Y. H., Gibbs, I. C., Soltys, S. G., Tse, V. C. K., Lieberson, R. E., … Chang, S. D. (2011). Multisession Stereotactic Radiosurgery for Vestibular Schwannomas: Single-Institution Experience With 383 Cases. NEUROSURGERY, 69(6), 1200–1209.
- Neuropilins are positive regulators of Hedgehog signal transduction
  Hillman, R. T., Feng, B. Y., Ni, J., Woo, W.-M., Milenkovic, L., Gephart, M. G. H., … Scott, M. P. (2011). Neuropilins are positive regulators of Hedgehog signal transduction. GENES & DEVELOPMENT, 25(22), 2333–46.
- A Population-Based Study of Inpatient Outcomes After Operative Management of Nontraumatic Intracerebral Hemorrhage in the United States
  Patil, C. G., Alexander, A. L., Gephart, M. G. H., Lad, S. P., Arrigo, R. T., & Boakye, M. (2012). A Population-Based Study of Inpatient Outcomes After Operative Management of Nontraumatic Intracerebral Hemorrhage in the United States. WORLD NEUROSURGERY, 78(6), 640–645.
- Primary Pediatric Skull Tumors
  Gephart, M. G. H., Colglazier, E., Paulk, K. L., Vogel, H., Guzman, R., & Edwards, M. S. B. (2011). Primary Pediatric Skull Tumors. PEDIATRIC NEUROSURGERY, 47(3), 198–203.
- Venous Thromboembolism After Thoracic/Thoracolumbar Spinal Fusion
  Gephart, M. G. H., Zygourakis, C. C., Arrigo, R. T., Kalanithi, P. S. A., Lad, S. P., & Boakye, M. (2012). Venous Thromboembolism After Thoracic/Thoracolumbar Spinal Fusion. WORLD NEUROSURGERY, 78(5), 545–52.
- Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.
  Hayden Gephart, M. G., Hansasuta, A., Balise, R. R., Choi, C., Sakamoto, G. T., Venteicher, A. S., … Chang, S. D. (2013). Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma. World Neurosurgery, 80(3-4), 359–63.
- Rehospitalization and emergency department use rates before and after vagus nerve stimulation for epilepsy: use of state databases to provide longitudinal data across multiple clinical settings.
  Kalanithi, P. S. A., Arrigo, R. T., Tran, P., Gephart, M. H., Shuer, L., Fisher, R., & Boakye, M. (2014). Rehospitalization and emergency department use rates before and after vagus nerve stimulation for epilepsy: use of state databases to provide longitudinal data across multiple clinical settings. Neuromodulation , 17(1), 60–64.
- Trends in the diagnosis and treatment of pediatric primary spinal cord tumors Clinical article
  Gephart, M. G. H., Lober, R. M., Arrigo, R. T., Zygourakis, C. C., Guzman, R., Boakye, M., … Fisher, P. G. (2012). Trends in the diagnosis and treatment of pediatric primary spinal cord tumors Clinical article. JOURNAL OF NEUROSURGERY-PEDIATRICS, 10(6), 555–59.
- Retrospective, Propensity Score-Matched Cohort Study Examining Timing of Fracture Fixation for Traumatic Thoracolumbar Fractures
  Boakye, M., Arrigo, R. T., Gephart, M. G. H., Zygourakis, C. C., & Lad, S. (2012). Retrospective, Propensity Score-Matched Cohort Study Examining Timing of Fracture Fixation for Traumatic Thoracolumbar Fractures. JOURNAL OF NEUROTRAUMA, 29(12), 2220–25.
- Trends in the diagnosis and treatment of pediatric primary spinal cord tumors.
  Hayden Gephart, M. G., Lober, R. M., Arrigo, R. T., Zygourakis, C. C., Guzman, R., Boakye, M., … Fisher, P. G. (2012). Trends in the diagnosis and treatment of pediatric primary spinal cord tumors. Journal of Neurosurgery. Pediatrics, 10(6), 555–59.
- Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.
  Moore, S. J., Hayden Gephart, M. G., Bergen, J. M., Su, Y. S., Rayburn, H., Scott, M. P., & Cochran, J. R. (2013). Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America, 110(36), 14598–603.
- Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma
  Gephart, M. G. H., Su, Y. R. S., Bandara, S., Tsai, F.-C., Hong, J., Conley, N., … Scott, M. P. (2013). Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma. JOURNAL OF NEURO-ONCOLOGY, 115(2), 161–68.
- Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma.
  Hayden Gephart, M. G., Su, Y. R. S., Bandara, S., Tsai, F.-C., Hong, J., Conley, N., … Scott, M. P. (2013). Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma. Journal of Neuro-Oncology, 115(2), 161–68.
- Using bioabsorbable fixation systems in the treatment of pediatric skull deformities leads to good outcomes and low morbidity
  Hayden Gephart, M. G., Woodard, J. I., Arrigo, R. T., Lorenz, H. P., Schendel, S. A., Edwards, M. S., & Guzman, R. (2013). Using bioabsorbable fixation systems in the treatment of pediatric skull deformities leads to good outcomes and low morbidity. Child's Nervous System, 29(2).
- Venous thromboembolism after thoracic/thoracolumbar spinal fusion
  Hayden Gephart, M. G., Zygourakis, C. C., Arrigo, R. T., Kalanithi, P. S., Lad, S. P., & Boakye, M. (2012). Venous thromboembolism after thoracic/thoracolumbar spinal fusion. World Neurosurgery, 78(5).
- Endoscopic third ventriculostomy and CyberKnife radiosurgery of a pineal parenchymal tumor of intermediate differentiation
  Chow, K. H., Hayden, M. G., Ziskin, J., Vogel, H., & Li, G. H. (2013). Endoscopic third ventriculostomy and CyberKnife radiosurgery of a pineal parenchymal tumor of intermediate differentiation. Cureus, 5(11).
- Retrospective, propensity score-matched cohort study examining timing of fracture fixation for traumatic thoracolumbar fractures
  Boakye, M., Arrigo, R. T., Hayden Gephart, M. G., Zygourakis, C. C., & Lad, S. (2012). Retrospective, propensity score-matched cohort study examining timing of fracture fixation for traumatic thoracolumbar fractures. Journal of Neurotrauma, 29(12).
- Primary pediatric skull tumors
  Hayden Gephart, M. G., Colglazier, E., Paulk, K. L., Vogel, H., Guzman, R., & Edwards, M. S. (2011). Primary pediatric skull tumors. Pediatric Neurosurgery, 47(3).
- Pediatric concussions in sports; a simple and rapid assessment tool for concussive injury in children and adults
  Hayden, M. G., Jandial, R., Duenas, H. A., Mahajan, R., & Levy, M. (2007). Pediatric concussions in sports; a simple and rapid assessment tool for concussive injury in children and adults. Child's Nervous System, 23(4), 431–5.
- Melatonin secretion in urban and rural Gambians
  Bickler, S. W., Williams, E., Hayden, M. G., Junger, W., & Hoyt, D. (2007). Melatonin secretion in urban and rural Gambians. Journal of Surgical Research, 137(2).
- Cushing's disease: predicting long-term remission after surgical treatment
  Pendharkar, A. V., Sussman, E. S., Ho, A. L., Gephart, M. G. H., & Katznelson, L. (2015). Cushing's disease: predicting long-term remission after surgical treatment. NEUROSURGICAL FOCUS, 38(2).
- Resident Away Rotations Allow Adaptive Neurosurgical Training.
  Gephart, M. H., Derstine, P., Oyesiku, N. M., Grady, M. S., Burchiel, K., Batjer, H. H., … Barbaro, N. M. (2015). Resident Away Rotations Allow Adaptive Neurosurgical Training. Neurosurgery.
- Brain Tumor Mutations Detected in Cerebral Spinal Fluid
  Pan, W., Gu, W., Nagpal, S., Gephart, M. H., & Quake, S. R. (2015). Brain Tumor Mutations Detected in Cerebral Spinal Fluid. CLINICAL CHEMISTRY, 61(3), 514–22.
- A survey of human brain transcriptome diversity at the single cell level
  Darmanis, S., Sloan, S. A., Zhang, Y., Enge, M., Caneda, C., Shuer, L. M., … Quake, S. R. (2015). A survey of human brain transcriptome diversity at the single cell level. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 112(23), 7285–90.
- Cervical Fracture Stabilization within 72 Hours of Injury is Associated with Decreased Hospitalization Costs with Comparable Perioperative Outcomes in a Propensity Score-Matched Cohort.
  Medress, Z., Arrigo, R. T., Hayden Gephart, M., Zygourakis, C. C., & Boakye, M. (2015). Cervical Fracture Stabilization within 72 Hours of Injury is Associated with Decreased Hospitalization Costs with Comparable Perioperative Outcomes in a Propensity Score-Matched Cohort. Cureus, 7(1).
- Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation.
  Medress, Z., & Hayden Gephart, M. (2015). Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation. Cureus, 7(1).
- Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
  Zhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., … Barres, B. A. (2016). Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. NEURON, 89(1), 37–53.
- Genetic and molecular distinctions in spinal ependymomas: A review.
  Connolly, I. D., Ali, R., Li, Y., & Gephart, M. H. (2015). Genetic and molecular distinctions in spinal ependymomas: A review. Clinical Neurology and Neurosurgery, 139, 210–15.
- New tools for studying microglia in the mouse and human CNS.
  Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., … Barres, B. A. (2016). New tools for studying microglia in the mouse and human CNS. Proceedings of the National Academy of Sciences of the United States of America, 113(12), E1738–46.
- New tools for studying microglia in the mouse and human CNS
  Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., … Barres, B. A. (2016). New tools for studying microglia in the mouse and human CNS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(12), E1738–E1746.
- The "Liquid Biopsy": the Role of Circulating DNA and RNA in Central Nervous System Tumors.
  Connolly, I. D., Li, Y., Gephart, M. H., & Nagpal, S. (2016). The "Liquid Biopsy": the Role of Circulating DNA and RNA in Central Nervous System Tumors. Current Neurology and Neuroscience Reports, 16(3), 25-?
- Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases
  Li, Y., Pan, W., Connolly, I. D., Reddy, S., Nagpal, S., Quake, S., & Gephart, M. H. (2016). Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases. JOURNAL OF NEURO-ONCOLOGY, 128(1), 93–100.
- Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.
  Moore, S. J., Hayden Gephart, M. G., Bergen, J. M., Su, Y. S., Rayburn, H., Scott, M. P., & Cochran, J. R. (2013). Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America, 110(36), 14598–603.
- Real-Time Fluoroscopic and C-Arm Computed Tomography Evaluation of Ommaya Reservoir Integrity.
  Moraff, A. M., Hayden Gephart, M., Shuer, L. M., & Heit, J. J. (2017). Real-Time Fluoroscopic and C-Arm Computed Tomography Evaluation of Ommaya Reservoir Integrity. Cureus, 9(3).
- Practice transition in graduate medical education.
  Shaffer, R., Piro, N., Katznelson, L., & Gephart, M. H. (2017). Practice transition in graduate medical education. The Clinical Teacher.
- Comparison of porcine and bovine collagen dural substitutes in posterior fossa decompression for Chiari I malformation in adults.
  Lee, C. K., Mokhtari, T., Connolly, I. D., Li, G., Shuer, L. M., Chang, S. D., … Gephart, M. H. (2017). Comparison of porcine and bovine collagen dural substitutes in posterior fossa decompression for Chiari I malformation in adults. World Neurosurgery.
- Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.
  Darmanis, S., Sloan, S. A., Croote, D., Mignardi, M., Chernikova, S., Samghababi, P., … Quake, S. R. (2017). Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma. Cell Reports, 21(5), 1399–1410.
- Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors.
  Vaca, S. D., Connolly, I. D., Ho, C., Neal, J., & Hayden Gephart, M. (2017). Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors. Neurosurgery.
- Chromosome-scale mega-haplotypes enable digital karyotyping of cancer aneuploidy
  Bell, J. M., Lau, B. T., Greer, S. U., Wood-Bouwens, C., Xia, L. C., Connolly, I. D., … Ji, H. P. (2017). Chromosome-scale mega-haplotypes enable digital karyotyping of cancer aneuploidy. NUCLEIC ACIDS RESEARCH, 45(19), e162.
- A Combination of Ontogeny and CNS Environment Establishes Microglial Identity.
  Bennett, F. C., Bennett, M. L., Yaqoob, F., Mulinyawe, S. B., Grant, G. A., Hayden Gephart, M., … Barres, B. A. (2018). A Combination of Ontogeny and CNS Environment Establishes Microglial Identity. Neuron.
- Recurrently Mutated Genes Differ between Leptomeningeal and Solid Lung Cancer Brain Metastases.
  Li, Y., Liu, B., Connolly, I. D., Kakusa, B. W., Pan, W., Nagpal, S., … Hayden Gephart, M. (2018). Recurrently Mutated Genes Differ between Leptomeningeal and Solid Lung Cancer Brain Metastases. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.
- Massive Intradural Chondroma Masquerading as Lower Body Parkinsonism.
  Connolly, I. D., Johnson, E., Lummus, S., & Hayden Gephart, M. (2018). Massive Intradural Chondroma Masquerading as Lower Body Parkinsonism. Cureus, 10(1), e2099.
- Single-Cell RNA-Sequencing in Glioma
  Johnson, E., Dickerson, K. L., Connolly, I. D., & Gephart, M. H. (2018). Single-Cell RNA-Sequencing in Glioma. CURRENT ONCOLOGY REPORTS, 20(5), 42.
- A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy
  Lamsam, L., Johnson, E., Connolly, I. D., Wintermark, M., & Gephart, M. H. (2018). A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy. NEUROSURGICAL FOCUS, 44(2), E10.
- A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma
  Connolly, I. D., Li, Y., Pan, W., Johnson, E., You, L., Vogel, H., … Gephart, M. H. (2017). A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma. JOURNAL OF NEURO-ONCOLOGY, 135(1), 29–36.
- Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.
  Chernikova, S. B., Nguyen, R. B., Truong, J. T., Mello, S. S., Stafford, J. H., Hay, M. P., … Brown, J. M. (2018). Dynamin impacts homology-directed repair and breast cancer response to chemotherapy. The Journal of Clinical Investigation.
- Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors.
  Chin, A. L., Fujimoto, D., Kumar, K. A., Tupper, L., Mansour, S., Chang, S. D., … Soltys, S. G. (2018). Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors. Neurosurgery.
- Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer.
  Kakusa, B., Han, S., Aggarwal, S., Liu, B., Li, G., Soltys, S., & Hayden Gephart, M. (2018). Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer. Journal of Neuro-Oncology.
- Cavernous malformations are rare sequelae of stereotactic radiosurgery for brain metastases.
  Seiger, K., Pendharkar, A. V., Samghabadi, P., Chang, S. D., Cho, N., Choi, C. Y., … Soltys, S. G. (2018). Cavernous malformations are rare sequelae of stereotactic radiosurgery for brain metastases. Acta Neurochirurgica.
- EGFR mutation status confers survival benefit in non-small cell lung cancer patients undergoing surgical resection of brain metastases: a retrospective cohort study.
  Huang, Y., Chow, K. K., Aredo, J. V., Padda, S. K., Han, S. S., Kakusa, B. W., & Gephart, M. H. (2019). EGFR mutation status confers survival benefit in non-small cell lung cancer patients undergoing surgical resection of brain metastases: a retrospective cohort study. World Neurosurgery.
- Socioeconomic Predictors of Pituitary Surgery
  Deb, S., Vyas, D. B., Pendharkar, A., Rezaii, P. G., Schoen, M. K., Desai, K., … Desai, A. (2019). Socioeconomic Predictors of Pituitary Surgery. CUREUS, 11(1).
- Socioeconomic Predictors of Pituitary Surgery.
  Deb, S., Vyas, D. B., Pendharkar, A. V., Rezaii, P. G., Schoen, M. K., Desai, K., … Desai, A. (2019). Socioeconomic Predictors of Pituitary Surgery. Cureus, 11(1), e3957.
- Foramen Magnum Meningioma with Brainstem Compression During Pregnancy.
  Choudhri, O., Ravikumar, V. K., & Gephart, M. H. (2016). Foramen Magnum Meningioma with Brainstem Compression During Pregnancy. World Neurosurgery, 91, 671.e9–671.e12.
- Real-Time Fluoroscopic and C-Arm Computed Tomography Evaluation of Ommaya Reservoir Integrity
  Moraff, A. M., Gephart, M. H., Shuer, L. M., & Heit, J. J. (2017). Real-Time Fluoroscopic and C-Arm Computed Tomography Evaluation of Ommaya Reservoir Integrity. CUREUS, 9(3).
- Epidermal Growth Factor Receptor Mutation Status Confers Survival Benefit in Patients with Non-Small-Cell Lung Cancer Undergoing Surgical Resection of Brain Metastases: A Retrospective Cohort Study
  Huang, Y., Chow, K. K. H., Aredo, J. V., Padda, S. K., Han, S. S., Kakusa, B. W., & Gephart, M. H. (2019). Epidermal Growth Factor Receptor Mutation Status Confers Survival Benefit in Patients with Non-Small-Cell Lung Cancer Undergoing Surgical Resection of Brain Metastases: A Retrospective Cohort Study. WORLD NEUROSURGERY, 125, E487–E496.
- Linked read whole genome sequencing reveals pervasive chromosomal level instability and novel rearrangements in brain metastases from colorectal cancer
  Xia, L. C., Bell, J. M., Wood-Bouwens, C., King, D. A., Shin, G. W., Greer, S., … Ji, H. P. (2018). Linked read whole genome sequencing reveals pervasive chromosomal level instability and novel rearrangements in brain metastases from colorectal cancer. CANCER RESEARCH, 78(13).
- Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors
  Vaca, S. D., Connolly, I. D., Ho, C., Neal, J., & Gephart, M. H. (2018). Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors. NEUROSURGERY, 82(1), E6–E14.
- Dynamin impacts homology-directed repair and breast cancer response to chemotherapy
  Chernikova, S. B., Nguyen, R. B., Truong, J. T., Mello, S. S., Stafford, J. H., Hay, M. P., … Brown, J. M. (2018). Dynamin impacts homology-directed repair and breast cancer response to chemotherapy. JOURNAL OF CLINICAL INVESTIGATION, 128(12), 5307–21.
- Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas.
  Shi, S., Jin, M. C., Koenig, J., Gibbs, I. C., Soltys, S. G., Chang, S. D., … Pollom, E. L. (2019). Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas. Stereotactic and Functional Neurosurgery, 1–6.
- Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.
  Turner, B. E., Prabhu, R. S., Burri, S. H., Brown, P. D., Pollom, E. L., Milano, M. T., … Soltys, S. G. (2019). Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability. International Journal of Radiation Oncology, Biology, Physics.
- Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.
  Kim, J. W., Marquez, C. P., Kostyrko, K., Koehne, A. L., Marini, K., Simpson, D. R., … Sweet-Cordero, E. A. (2019). Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma. Nature Medicine.
- Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors
  Chin, A. L., Fujimoto, D., Kumar, K. A., Tupper, L., Mansour, S., Chang, S. D., … Soltys, S. G. (2019). Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors. NEUROSURGERY, 85(5), 708–16.
- Non-Contrast T2-Weighted MR Sequences for Long Term Monitoring of Asymptomatic Convexity Meningiomas.
  He, J. Q., Iv, M., Li, G., Zhang, M., & Hayden-Gephart, M. (2019). Non-Contrast T2-Weighted MR Sequences for Long Term Monitoring of Asymptomatic Convexity Meningiomas. World Neurosurgery.
- Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities.
  Shi, S., Sandhu, N., Jin, M. C., Wang, E., Jaoude, J. A., Schofield, K., … Pollom, E. L. (2019). Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities. International Journal of Radiation Oncology, Biology, Physics.
- Outcomes and costs following Ommaya placement with thrombocytopenia among US cancer patients.
  Zhang, M., Zhang, Y., Zheng, E., Gephart, M. H., Veeravagu, A., Desai, A., … Li, G. (2019). Outcomes and costs following Ommaya placement with thrombocytopenia among US cancer patients. World Neurosurgery.
- A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes.
  Azoulay, M., Chang, S. D., Gibbs, I. C., Hancock, S. L., Pollom, E. L., Harsh, G. R., … Soltys, S. G. (2020). A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes. Neuro-Oncology.
- A NOVEL BRAIN-PERMEANT CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS
  Deng, J., Chernikova, S., Fischer, W.-N., Koller, K., Jandeleit, B., Ringold, G., & Gephart, M. H. (2019). A NOVEL BRAIN-PERMEANT CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS. NEURO-ONCOLOGY, 21, 70.
- EVALUATION OF DYNAMIN 2 (DNM2) AS A THERAPEUTIC TARGET IN LEPTOMENINGEAL METASTATIC DISEASE
  Chernikova, S., Polyak, D., Deng, J., Tsau, S., Casey, K., Johnson, E., … Gephart, M. H. (2019). EVALUATION OF DYNAMIN 2 (DNM2) AS A THERAPEUTIC TARGET IN LEPTOMENINGEAL METASTATIC DISEASE. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- COMPREHENSIVE RNA ANALYSIS OF CEREBROSPINAL FLUID FROM LEPTOMENINGEAL METASTASES
  Polyak, D., Li, Y., Liu, B., Connolly, I., Khoeur, L., Kakusa, B. W., … Gephart, M. H. (2019). COMPREHENSIVE RNA ANALYSIS OF CEREBROSPINAL FLUID FROM LEPTOMENINGEAL METASTASES. NEURO-ONCOLOGY, 21, 62.
- Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin.
  Sandhu, N., Benson, K. R., Kumar, K. A., Eyben, R. V., Chang, D. T., Gibbs, I. C., … Pollom, E. L. (2020). Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin. Journal of Neurosurgery. Spine, 1–8.
- Prostate Cancer Brain Metastases: A Single-Institution Experience.
  Bhambhvani, H. P., Greenberg, D. R., Srinivas, S., & Gephart, M. H. (2020). Prostate Cancer Brain Metastases: A Single-Institution Experience. World Neurosurgery.
- Costs and Complications Associated with Resection of Supratentorial Tumors with and without the Operative Microscope in the United States.
  Zhang, Y., Zhang, M., Lin, M., Gephart, M. H., Veeravagu, A., Ratliff, J. K., & Li, G. (2020). Costs and Complications Associated with Resection of Supratentorial Tumors with and without the Operative Microscope in the United States. World Neurosurgery.
- Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study.
  Bhambhvani, H. P., Rodrigues, A. J., Medress, Z. A., & Hayden Gephart, M. (2020). Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study. Journal of Neuro-Oncology.
- Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
  Jin, M. C., Liu, E. K., Shi, S., Gibbs, I. C., Thomas, R., Recht, L., … Li, G. (2020). Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma. Frontiers in Oncology, 10, 337.
- Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience.
  Falkson, S. R., Bhambhvani, H. P., & Gephart, M. H. (2020). Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience. World Neurosurgery.
- Stereotactic Radiosurgery for Resected Brain Metastases - Does the Surgical Corridor Need to be Targeted?
  Shi, S., Sandhu, N., Jin, M., Wang, E., Liu, E., Jaoude, J. A., … Soltys, S. G. (2020). Stereotactic Radiosurgery for Resected Brain Metastases - Does the Surgical Corridor Need to be Targeted? Practical Radiation Oncology.
- Difference-Frequency Ultrasound Imaging With Non-Linear Contrast
  Li, Y., Polyak, D., Johnson, E., Yecies, D., Shevidi, S., de la Zerda, A., … Chu, S. (2020). Difference-Frequency Ultrasound Imaging With Non-Linear Contrast. IEEE TRANSACTIONS ON MEDICAL IMAGING, 39(5), 1759–66.
- Executive Summary from American Radium Society's Appropriate Use Criteria on Neurocognition after stereotactic radiosurgery for multiple brain metastases.
  Milano, M. T., Chiang, V. L., Soltys, S. G., Wang, T. J., Lo, S. S., Brackett, A., … Chang, E. L. (2020). Executive Summary from American Radium Society's Appropriate Use Criteria on Neurocognition after stereotactic radiosurgery for multiple brain metastases. Neuro-Oncology.
- Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma.
  Zhang, M., Rodrigues, A. J., Bhambhvani, H. P., Fatemi, P., Pollom, E. L., Gibbs, I. C., … Li, G. (2020). Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma. World Neurosurgery.
- Commentary: Predicting Postoperative Outcomes in Brain Tumor Patients With a 5-Factor Modified Frailty Index.
  Zhang, M., Hayden Gephart, M., & Zygourakis, C. C. (2020). Commentary: Predicting Postoperative Outcomes in Brain Tumor Patients With a 5-Factor Modified Frailty Index. Neurosurgery.
- Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.
  Bhambhvani, H. P., Rodrigues, A. J., Umeh-Garcia, M. C., & Hayden Gephart, M. (2020). Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies. Neurosurgery Clinics of North America, 31(4), 613–25.
- Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States.
  Chin, A. L., Li, G., Gephart, M. H., Sandhu, N., Nagpal, S., Soltys, S. G., & Pollom, E. L. (2020). Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States. World Neurosurgery.
- The primary sites leading to brain metastases: Shifting trends at a tertiary care center.
  Bhambhvani, H. P., Granucci, M., Rodrigues, A., Kakusa, B. W., & Hayden Gephart, M. (2020). The primary sites leading to brain metastases: Shifting trends at a tertiary care center. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 80, 121–24.
- Hospital Volumes of 5 Medical Emergencies in the COVID-19 Pandemic in 2 US Medical Centers.
  Bhambhvani, H. P., Rodrigues, A. J., Yu, J. S., Carr, J. B., & Hayden Gephart, M. (2020). Hospital Volumes of 5 Medical Emergencies in the COVID-19 Pandemic in 2 US Medical Centers. JAMA Internal Medicine.
- PREOPERATIVE SINGLE FRACTION RADIOSURGERY VERSUS POSTOPERATIVE FRACTIONATED RADIOSURGERY FOR RESECTED BRAIN METASTASES: A BI-INSTITUTIONAL ANALYSIS OF SAFETY AND CLINICAL OUTCOMES
  Prabhu, R., Shi, S., Dhakal, R., Soltys, S., Burri, S., Asher, A., … Pollom, E. (2020). PREOPERATIVE SINGLE FRACTION RADIOSURGERY VERSUS POSTOPERATIVE FRACTIONATED RADIOSURGERY FOR RESECTED BRAIN METASTASES: A BI-INSTITUTIONAL ANALYSIS OF SAFETY AND CLINICAL OUTCOMES. NEURO-ONCOLOGY, 22, 184.
- Brain Metastases from Endometrial Cancer: Clinical Characteristics, Outcomes, and Review of the Literature.
  Bhambhvani, H. P., Zhou, O., Cattle, C., Taiwo, R., Diver, E., & Gephart, M. H. (2020). Brain Metastases from Endometrial Cancer: Clinical Characteristics, Outcomes, and Review of the Literature. World Neurosurgery.
- Report from the American Radium Society (ARS) Appropriate Use Criteria Brain Malignancies Panel: Treatment of Multiple Brain Metastases
  Milano, M., Chiang, V., Soltys, S., Wang, T., Lo, S., Brackett, A., … Chang, E. (2020). Report from the American Radium Society (ARS) Appropriate Use Criteria Brain Malignancies Panel: Treatment of Multiple Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
  Zhang, M., Rodrigues, A. J., Pollom, E. L., Gibbs, I. C., Soltys, S. G., Hancock, S. L., … Li, G. (2021). Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases. Journal of Neuro-Oncology.
- Management of brain tumors presenting in pregnancy: a case series and systematic review
  Rodrigues, A. (2021). Management of brain tumors presenting in pregnancy: a case series and systematic review. Management of Brain Tumors Presenting in Pregnancy: a Case Series and Systematic Review, 3(1).
- Management of brain tumors presenting in pregnancy: a case series and systematic review.
  Rodrigues, A. J., Waldrop, A. R., Suharwardy, S., Druzin, M. L., Iv, M., Ansari, J. R., … Hayden-Gephart, M. (2021). Management of brain tumors presenting in pregnancy: a case series and systematic review. American Journal of Obstetrics & Gynecology MFM, 3(1), 100256.
- Financial Toxicity in Patients with Brain and Spine Metastases.
  Koenig, J. L., Sandhu, N., Sborov, K., Sabolch, A., Usoz, M., Li, G., … Pollom, E. L. (2021). Financial Toxicity in Patients with Brain and Spine Metastases. World Neurosurgery.
- Patient Experience and Satisfaction with Telemedicine During Coronavirus Disease 2019: A Multi-Institution Experience.
  Rodrigues, A., Yu, J. S., Bhambhvani, H., Uppstrom, T., Ricci, W. M., Dines, J. S., & Hayden-Gephart, M. (2021). Patient Experience and Satisfaction with Telemedicine During Coronavirus Disease 2019: A Multi-Institution Experience. Telemedicine Journal and e-Health : the Official Journal of the American Telemedicine Association.
- Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas.
  Rodrigues, A., Bhambhvani, H., Medress, Z. A., Malhotra, S., & Hayden-Gephart, M. (2021). Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas. Journal of Neuro-Oncology.
- A Combination of Ontogeny and CNS Environment Establishes Microglial Identity
  Bennett, F. C., Bennett, M. L., Yaqoob, F., Mulinyawe, S. B., Grant, G. A., Gephart, M. H., … Barres, B. A. (2018). A Combination of Ontogeny and CNS Environment Establishes Microglial Identity. NEURON, 98(6), 1170-+.
- Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer
  Kakusa, B., Han, S., Aggarwal, S., Liu, B., Li, G., Soltys, S., & Gephart, M. H. (2018). Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer. JOURNAL OF NEURO-ONCOLOGY, 140(3), 705–715.
- Recurrently Mutated Genes Differ between Leptomeningeal and Solid Lung Cancer Brain Metastases
  Li, Y., Liu, B., Connolly, I. D., Kakusa, B. W., Pan, W., Nagpal, S., … Gephart, M. H. (2018). Recurrently Mutated Genes Differ between Leptomeningeal and Solid Lung Cancer Brain Metastases. JOURNAL OF THORACIC ONCOLOGY, 13(7), 1022–1027.
- EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
  Zhou, Q., van den Berg, N. S., Rosenthal, E. L., Iv, M., Zhang, M., Vega Leonel, J. C. M., … Li, G. (2021). EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial. Theranostics, 11(15).
- A Novel Protocol for Reducing Intensive Care Utilization After Craniotomy.
  Pendharkar, A. V., Shahin, M. N., Awsare, S. S., Ho, A. L., Wachira, C., Clevinger, J., … Gephart, M. H. (2021). A Novel Protocol for Reducing Intensive Care Utilization After Craniotomy. Neurosurgery.
- EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
  Zhou, Q., van den Berg, N. S., Rosenthal, E. L., Iv, M., Zhang, M., Vega Leonel, J. C., … Li, G. (2021). EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial. Theranostics, 11(15), 7130–7143.
- A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma.
  Beinat, C., Patel, C. B., Haywood, T., Murty, S., Naya, L., Castillo, J. B., … Gambhir, S. S. (2021). A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Cavernous malformations are rare sequelae of stereotactic radiosurgery for brain metastases
  Seiger, K., Pendharkar, A. V., Samghabadi, P., Chang, S. D., Cho, N., Choi, C. Y. H., … Soltys, S. G. (2019). Cavernous malformations are rare sequelae of stereotactic radiosurgery for brain metastases. ACTA NEUROCHIRURGICA, 161(1), 43–48.
- Massive Intradural Chondroma Masquerading as Lower Body Parkinsonism
  Connolly, I. D., Johnson, E., Lummus, S., & Gephart, M. H. (2018). Massive Intradural Chondroma Masquerading as Lower Body Parkinsonism. CUREUS, 10(1).
- Cervical Fracture Stabilization within 72 Hours of Injury is Associated with Decreased Hospitalization Costs with Comparable Perioperative Outcomes in a Propensity Score-Matched Cohort
  Medress, Z., Arrigo, R. T., Gephart, M. H., Zygourakis, C. C., & Boakye, M. (2015). Cervical Fracture Stabilization within 72 Hours of Injury is Associated with Decreased Hospitalization Costs with Comparable Perioperative Outcomes in a Propensity Score-Matched Cohort. CUREUS, 7(1).
- Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma
  Hui, C., Wu, Y. (F., Liu, K., Sandhu, N., Blomain, E., Binkley, M., … Pollom, E. (2021). Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- American Radium Society Appropriate Use Criteria for the Management of Brain Metastases in EGFR-mutated Non-Small Cell Lung Cancer
  Nagpal, S., Chiang, V., Milano, M., Soltys, S., Ahluwalia, M., Chao, S., … Chang, E. (2021). American Radium Society Appropriate Use Criteria for the Management of Brain Metastases in EGFR-mutated Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- American Radium Society's Appropriate Use Criteria on Postoperative Management of Lower Grade Gliomas
  Tom, M., Milano, M., Soltys, S., Sahgal, A., Knisely, J., Chiang, V., … Chang, E. (2021). American Radium Society's Appropriate Use Criteria on Postoperative Management of Lower Grade Gliomas. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer.
  Deng, J., Chernikova, S. B., Wang, Y., Rodriguez, M. L., Andersen, S. J., Umeh-Garcia, M. C., … Gephart, M. H. (2021). A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics.
- Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases.
  Li, Y., Polyak, D., Lamsam, L., Connolly, I. D., Johnson, E., Khoeur, L. K., … Hayden Gephart, M. (2021). Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases. NPJ Precision Oncology, 5(1), 90.
- High-quality neurosurgeon communication and visualization during telemedicine encounters improves patient satisfaction
  Rodrigues, A., Li, G., Zhang, M., Jin, M., & Hayden-Gephart, M. (2021). High-quality neurosurgeon communication and visualization during telemedicine encounters improves patient satisfaction. Journal of Clinical Neuroscience, 94.
- Socioeconomic disparities in brain metastasis survival and treatment: a population-based study.
  Rodrigues, A., Li, G., Bhambhvani, H., & Hayden-Gephart, M. (2021). Socioeconomic disparities in brain metastasis survival and treatment: a population-based study. World Neurosurgery.
- An updated comparison between WHO grade 2 gemistocytic and diffuse astrocytoma survival and treatment patterns.
  Rodrigues, A., Zhang, M., Toland, A., Bhambhvani, H., & Hayden-Gephart, M. (2021). An updated comparison between WHO grade 2 gemistocytic and diffuse astrocytoma survival and treatment patterns. World Neurosurgery.
- A Case of Isolated Leptomeningeal Progression in a Patient with NTRK Fusion plus Uterine Sarcoma
  Lanman, T., Hayden, M., Bui, N., & Nagpal, S. (2021). A Case of Isolated Leptomeningeal Progression in a Patient with NTRK Fusion plus Uterine Sarcoma. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Isolated Leptomeningeal Progression in a Patient with NTRK Fusion+ Uterine Sarcoma: A Case Report.
  Lanman, T., Hayden Gephart, M., Bui, N., Toland, A., & Nagpal, S. (2021). Isolated Leptomeningeal Progression in a Patient with NTRK Fusion+ Uterine Sarcoma: A Case Report. Case Reports in Oncology, 14(3), 1841–1846.
- In Reply: A Novel Protocol for Reducing Intensive Care Utilization After Craniotomy.
  Pendharkar, A. V., Shahin, M. N., Awsare, S. S., Ho, A. L., Wachira, C., Clevinger, J., … Hayden, M. G. (1800). In Reply: A Novel Protocol for Reducing Intensive Care Utilization After Craniotomy. Neurosurgery.
- Factors for differential outcome across cancers in clinical molecular-targeted fluorescence imaging.
  Zhou, Q., van den Berg, N. S., Kang, W., Pei, J., Nishio, N., van Keulen, S., … Rosenthal, E. L. (2022). Factors for differential outcome across cancers in clinical molecular-targeted fluorescence imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine.
- Executive summary of american radium society's appropriate use criteria for the postoperative management of lower grade gliomas.
  Tom, M. C., Milano, M. T., Chao, S. T., Soltys, S. G., Knisely, J. P., Sahgal, A., … Chang, E. L. (2022). Executive summary of american radium society's appropriate use criteria for the postoperative management of lower grade gliomas. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology.
- Biliary cancer brain metastases: a multi-institution case series with case reports
  Falkson, S. R., Zhang, K., Bhambhvani, H. P., Wild, J. L., Griffin, A., Kelley, R. K., & Gephart, M. H. (2022). Biliary cancer brain metastases: a multi-institution case series with case reports. JOURNAL OF GASTROINTESTINAL ONCOLOGY.
- Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
  Umeh-Garcia, M., O'Geen, H., Simion, C., Gephart, M. H., Segal, D. J., & Sweeney, C. A. (2022). Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer. British Journal of Cancer.
- DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery.
  ‡Kuo, F., ‡Ng, N. N., Nagpal, S., Pollom, E. L., Soltys, S., Hayden-Gephart, M., … Iv, M. (2022). DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery. American Journal of Neuroradiology, 43(5).
- Biliary cancer brain metastases: a multi-institution case series with case reports.
  Falkson, S. R., Zhang, K., Bhambhvani, H. P., Wild, J. L., Griffin, A., Kelley, R. K., & Gephart, M. H. (2022). Biliary cancer brain metastases: a multi-institution case series with case reports. Journal of Gastrointestinal Oncology, 13(2), 822–832.
- Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival
  Mendoza, M., Janchenko, L., von Eyben, R., Kidd, E., Pollom, E., Chang, S., … Soltys, S. (2022). Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes.
  Wu, J., Ding, V., Luo, S., Choi, E., Hellyer, J., Myall, N., … Han, S. S. (2022). Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology, 6, e2200220.
- Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer.
  Hui, C., Qu, V., Wang, J.-Y. Y., von Eyben, R., Chang, Y.-C. C., Chiang, P.-L. L., … Pollom, E. (2022). Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer. Journal of Neuro-Oncology.
- 5-Aminolevulinic Acid Imaging of Malignant Glioma.
  Li, G., Rodrigues, A., Kim, L., Garcia, C., Jain, S., Zhang, M., & Hayden-Gephart, M. (2022). 5-Aminolevulinic Acid Imaging of Malignant Glioma. Surgical Oncology Clinics of North America, 31(4), 581–593.
- Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival.
  Xiong, Z., Wu, S., Li, F.-J., Luo, C., Jin, Q.-Y., Connolly, I. D., … You, L. (2022). Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival. Genes, 13(10).
- Stereotactic radiosurgery for trigeminal neuralgia secondary to tumor: a single-institution retrospective series.
  Hall, J. C., Ung, T. H., McCleary, T.-L. L., Chuang, C., Gibbs, I. C., Soltys, S. G., … Meola, A. (2022). Stereotactic radiosurgery for trigeminal neuralgia secondary to tumor: a single-institution retrospective series. Neurosurgical Focus, 53(5), E3.
- MICROGLIA REPLACEMENT CHANGES THE TRANSCRIPTIONAL PROFILE OF TUMOR ASSOCIATED MYELOID CELLS IN MURINE MODELS OF BRAIN MALIGNANCIES
  Mader, M., Rodrigues, A., Chernikova, S., Wong, Z. H. S., Wang, Y., Petritsch, C., … Gephart, M. H. (2022). MICROGLIA REPLACEMENT CHANGES THE TRANSCRIPTIONAL PROFILE OF TUMOR ASSOCIATED MYELOID CELLS IN MURINE MODELS OF BRAIN MALIGNANCIES. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma.
  Hui, C., Wu, Y. F., Liu, K., Sandhu, N., Blomain, E., Binkley, M. S., … Pollom, E. (2022). Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma. Cureus, 14(11), e31838.
- A Protocol for Reducing Intensive Care Utilization After Craniotomy: A 3-Year Assessment.
  Ruiz Colón, G. D., Ohkuma, R., Pendharkar, A. V., Heifets, B. D., Li, G., Lu, A., … Ratliff, J. K. (2023). A Protocol for Reducing Intensive Care Utilization After Craniotomy: A 3-Year Assessment. Neurosurgery.
- Patterns of Progression in Patients with Newly Diagnosed Glioblastoma Treated with 5 mm Margins on a Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery with Concurrent and Adjuvant Temozolomide.
  Mendoza, M. G., Azoulay, M., Chang, S. D., Gibbs, I. C., Hancock, S. L., Pollom, E. L., … Soltys, S. G. (2023). Patterns of Progression in Patients with Newly Diagnosed Glioblastoma Treated with 5 mm Margins on a Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery with Concurrent and Adjuvant Temozolomide. Practical Radiation Oncology.
- Proof of Principle for Intracarotid Injection of Leukemia As Model for Late Stage Central Nervous System Leukemia
  Wang, C., Rodrigues, A., Chernikova, S., Davis, K. L., & Gephart, M. H. (2022). Proof of Principle for Intracarotid Injection of Leukemia As Model for Late Stage Central Nervous System Leukemia. BLOOD. AMER SOC HEMATOLOGY.
- Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
  Hui, C., Qu, V., Wang, J. Y., Von Eyben, R., Chang, Y. C., Chiang, P. L., … Pollom, E. (2022). Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Stereotactic Radiosurgery for Brain Metastases in Patients With a Heterozygous Germline Ataxia Telangiectasia Mutated Gene.
  Hall, J. C., Chang, S. D., Gephart, M. H., Pollom, E., & Butler, S. (2023). Stereotactic Radiosurgery for Brain Metastases in Patients With a Heterozygous Germline Ataxia Telangiectasia Mutated Gene. Cureus, 15(4), e37712.
- Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation
  Medress, Z., & Gephart, M. H. (2015). Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation. CUREUS JOURNAL OF MEDICAL SCIENCE, 7(1).
- National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
  Kim, M. M., Mehta, M. P., Smart, D. D. K., Steeg, P. S., Hong, J. A., Espey, M. G., … Ahmed, M. M. (2023). National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. The Lancet. Oncology, 24(8), e344–e354.
- Roadmap for Successful Research Training in Neurosurgery.
  Hayden Gephart, M., Holly, L. T., Amin-Hanjani, S., Zipfel, G. J., Mack, W. J., Tennekoon, M., & Korn, S. (2023). Roadmap for Successful Research Training in Neurosurgery. Neurosurgery, 93(3), e46–e52.
- Roadmap for Development of a Strong, Diverse Research Workforce in Neurosurgery.
  Hayden Gephart, M., Holly, L. T., Amin-Hanjani, S., Zipfel, G. J., Mack, W. J., Tennekoon, M., & Korn, S. (2023). Roadmap for Development of a Strong, Diverse Research Workforce in Neurosurgery. Neurosurgery, 93(3), e53–e58.
- National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities
  Kim, M. M., Mehta, M. P., Smart, D. D. K., Steeg, P. S., Hong, J. A., Espey, M. G., … Ahmed, M. M. (2023). National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. LANCET ONCOLOGY, 24(8), E344–E354.
- Impact of language barriers and use of interpreters on hope among patients with Central Nervous System Malignancies and Bone Metastases.
  Hui, C., Hall, J., Fang, Z., Lefebvre, S., Hayden-Gephart, M., Li, G., … Pollom, E. (2023). Impact of language barriers and use of interpreters on hope among patients with Central Nervous System Malignancies and Bone Metastases. International Journal of Radiation Oncology, Biology, Physics.
- Neuroinvasive Francisella tularensis Infection: Report of 2 Cases and Review of the Literature.
  Cash-Goldwasser, S., Beeson, A., Marzec, N., Ho, D. Y., Hogan, C. A., Budvytiene, I., … Nelson, C. A. (2024). Neuroinvasive Francisella tularensis Infection: Report of 2 Cases and Review of the Literature. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 78(Supplement_1), S55–S63.
- SPATIALLY-RESOLVED TRANSCRIPTOME ANALYSIS OF BRAIN METASTATIC BREAST CANCER REVEAL KEY MEDIATORS OF BRAIN-TROPIC METASTATIC POTENTIAL
  Umeh-Garcia, M., Godfrey, B., Perez, P. N., Varma, S., Ahmadian, S., Toland, A., … Gephart, M. H. (2023). SPATIALLY-RESOLVED TRANSCRIPTOME ANALYSIS OF BRAIN METASTATIC BREAST CANCER REVEAL KEY MEDIATORS OF BRAIN-TROPIC METASTATIC POTENTIAL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- INTERNAL CAROTID INJECTION MODEL OF BRAIN METASTASIS DESCRIBES LEPTOMENINGEAL DISEASE
  Chernikova, S., Tsau, S., Wang, Y., Hartmann, G., Polyak, D., Bhambhvani, H., … Gephart, M. H. (2023). INTERNAL CAROTID INJECTION MODEL OF BRAIN METASTASIS DESCRIBES LEPTOMENINGEAL DISEASE. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Repurposing mebendazole against triple-negative breast cancer leptomeningeal disease.
  Rodrigues, A., Chernikova, S. B., Wang, Y., Trinh, T. T., Solow-Cordero, D. E., Alexandrova, L., … Hayden-Gephart, M. (2024). Repurposing mebendazole against triple-negative breast cancer leptomeningeal disease. Research Square.
- Executive Summary of the American Radium Society Appropriate Use Criteria for Brain Metastases in EGFR-mutated and ALK-fusion Non-Small Cell Lung Cancer.
  Nagpal, S., Milano, M. T., Chiang, V. L., Soltys, S. G., Brackett, A., Halasz, L. M., … Chang, E. L. (2024). Executive Summary of the American Radium Society Appropriate Use Criteria for Brain Metastases in EGFR-mutated and ALK-fusion Non-Small Cell Lung Cancer. Neuro-Oncology.
- Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
  Rodrigues, A. J., Chernikova, S. B., Wang, Y., Trinh, T. T., Solow-Cordero, D. E., Alexandrova, L., … Hayden-Gephart, M. (2024). Repurposing mebendazole against triple-negative breast cancer CNS metastasis. Journal of Neuro-Oncology.
- Cerebral perivascular spaces as predictors of dementia risk and accelerated brain atrophy.
  Barisano, G., Iv, M., Choupan, J., & Hayden-Gephart, M. (2024). Cerebral perivascular spaces as predictors of dementia risk and accelerated brain atrophy. MedRxiv : the Preprint Server for Health Sciences.
- Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis.
  Azad, T. D., Nanjo, S., Jin, M. C., Chabon, J. J., Kurtz, D. M., Chaudhuri, A. A., … Diehn, M. (2024). Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis. NPJ Precision Oncology, 8(1), 121.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Specializing In

Acoustic Neuroma (Vestibular Schwannoma)
Advanced Solid Tumors
Brain Metastases
Brain Tumors
Cancer
Cancer Cell Biology
Cancer Surgery
Cavernous Malformation
Central nervous system tumors
Cranial base surgery
Cranial Nerve Schwannomas
CyberKnife Stereotactic Radiosurgery
Glioblastoma
Glioma

Keyhole Surgery

Laser Interstitial Thermal Therapy
Leptomeningeal Metastases
Meningioma
Meningioma of the Skull Base
Neurological Surgery
Neurosurgical Oncology
Primary Brain Cancer
Radiation for Brain Tumors
Radiosurgery
Skull Base Surgery
Skull Base Tumors
Surgery for Acoustic Neuroma
Surgery for Brain Tumors
Surgery for Glioma, Glioblastoma, & Astrocytoma

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(29 Ratings)

Overall Rating

4.9/5

View Ratings by Category

5.0/5

Friendliness

4.9/5

Explanations

5.0/5

Listens

4.9/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(160 reviews)

Dr. Hayden is excellent! No comments or suggestions.

Sep 2024

•

Verified SHC Patient

Dr. Hayden Gephart was professional and respectful. She explained her opinion well and allowed us to ask questions regarding our sonâ€™s diagnosis and proposed treatment plan. She is an excellent asset to Stanford Medicine.

Aug 2024

•

Verified SHC Patient

Dr. Hayden is very professional and compassionate.

Aug 2024

•

Verified SHC Patient

I wish there were more doctors like her, ver thourough and easy to understand

Aug 2024

•

Verified SHC Patient

Thank you

Jul 2024

•

Verified SHC Patient

Excellent

Jul 2024

•

Verified SHC Patient

Excellent

Jul 2024

•

Verified SHC Patient

Dr. Hayden is so incredible! When we first met I didnâ€™t have much hope. I was so stressed. When she started to explain her thoughts and how she wanted to proceed with my care it felt like an elephant jumped off my chest and I could breathe again! After the first MRI I had in the Stanford Imaging Center in Redwood City Dr.Hayden showed us exactly what was going on in my head. From that visit on I started to feel there was a future I could look forward to. When she thought surgery was the next step in my care I never had a second thought about having it. She is an extraordinary doctor and surgeon . I am so Blessed to be under her care.

Jun 2024

•

Verified SHC Patient

Thank you for your excellent care.

Jun 2024

•

Verified SHC Patient

Excellent caring Dr. see prior note. I trust her

May 2024

•

Verified SHC Patient

Am very happy with her and she is easy to for me to understand the medical parts too. Also like her nurse very much too. I happen to forget her name,, but she is very good too. Love them both

May 2024

•

Verified SHC Patient

She seems like an excellent neurosurgeon.

May 2024

•

Verified SHC Patient

Dr. Hayden is incredible. She â€œtalksâ€ to me, doesnâ€™t rush, explains whatâ€™s going on, answers all my questions and concerns in away I understand. She welcomes my husbandâ€™s questions , the â€œgoogle doctorâ€ , and makes him feel comfortable asking them. Dr Hayden has been so supportive and so wonderful. Sheâ€™s an incredibly gifted doctor that I am so thankful to be her patient.

Mar 2024

•

Verified SHC Patient

Outstanding Performance, caring

Mar 2024

•

Verified SHC Patient

She is a superstar neurosurgeon. Dr. Hayden and team gave me back my life! Iâ€™m feeling great and itâ€™s all due to the diligence of this team! My family and I thank you for another chance at life.

Mar 2024

•

Verified SHC Patient

Thank you for your time.

Feb 2024

•

Verified SHC Patient

She's a fantastic doctor. I have complete confidence in her!

Feb 2024

•

Verified SHC Patient

The Stanford hospital is a very important for every one

Jan 2024

•

Verified SHC Patient

Dr Hayden was simply outstanding!

Jan 2024

•

Verified SHC Patient

I am beyond grateful to her. She is a proactive and knowledgeable doctor. I trust her completely with my care which I find to be a gift.

Jan 2024

•

Verified SHC Patient

Doctor Hayden is a great doctor that cares and understands her patients n wants to help them get better

Jan 2024

•

Verified SHC Patient

Sheâ€™s a wonderful doctor very kind and provides clear understanding of my health issues and treatments and results from tests

Jan 2024

•

Verified SHC Patient

Excellent Doctor extremely patient and explains everything well and in detail.

Dec 2023

•

Verified SHC Patient

Very happy I have herâ€¦. I think she is the best there is

Dec 2023

•

Verified SHC Patient

Wonderful doctor!

Dec 2023

•

Verified SHC Patient

She is very informative and calming.

Nov 2023

•

Verified SHC Patient

Thank you Dr. Hayden for a great video visit. Itâ€™s very helpful and informative!

Nov 2023

•

Verified SHC Patient

Dr. Hayden Gephart was wonderful to talk to we really enjoyed our visit

Nov 2023

•

Verified SHC Patient

Excellent doctor and very efficiently on her diagnostics and treatment. Very happy to have her as my doctor.

Nov 2023

•

Verified SHC Patient

I very much appreciated her thoroughness, bedside manner, and commitment to figuring out the true nature of the medical condition.

Sep 2023

•

Verified SHC Patient

Dr, Hayden was compassionate, professional, informative and very kind. She and her check in nurse were wonderful at making me feel as comfortable as possible during my visit. So very grateful.

Sep 2023

•

Verified SHC Patient

Great team.

Sep 2023

•

Verified SHC Patient

I love the care that Dr. Hayden-Gephart provides. She is a fantastic surgeon! She listens to concerns, questions, needs, etc. 10 out of 10; five stars out of five stars. I am so grateful to her and the staff at Stanford.

Sep 2023

•

Verified SHC Patient

She is a wonderful doctor & I feel privileged to have her caring for me

Aug 2023

•

Verified SHC Patient

Very professional, straightforward and outlined our care plan as we go forward

Aug 2023

•

Verified SHC Patient

Good doctor

Jul 2023

•

Verified SHC Patient

Excellent Surgeon easy approach and tells us what is good for the patient.

Jun 2023

•

Verified SHC Patient

Dr. Hayden was very reassuring, felt very thankful after my visit.

Jun 2023

•

Verified SHC Patient

Dr. Gephart is extremely approachable. Her kind and intelligent demeanor put me right at ease. Could not have been better.

Jun 2023

•

Verified SHC Patient

Dr Hayden Gephart is most knowledgeable and helpful. She has a wonderful â€œbedside mannerâ€ and makes me feel confident that she has all of my vast medical issues in mind in her decision making. I feel very fortunate that sheâ€™s my doctor.

May 2023

•

Verified SHC Patient

Dr. Hayden was wonderful with my husband and I. She was extremely reassuring, she didnâ€™t hesitate to answer any of our questions, she didnâ€™t avoid any of our questions or fumble around answers that might be unpleasant for us to hear.. We felt very comfortable with her. We have total trust in her and feel she will help us to make the right decision for treatment.

May 2023

•

Verified SHC Patient

She was engaged with us throughout the video visit and provided reliable and sound recommendations. She seems like a genuinely kind doctor. We are both glad she was recommended by my husband's radiation oncologist.

Apr 2023

•

Verified SHC Patient

Enjoy working with her.

Apr 2023

•

Verified SHC Patient

She is very professional and pleasant. She answers all questions and repeats when necessary.

Apr 2023

•

Verified SHC Patient

Dr Melanie Hayden Gephart. is great!

Feb 2023

•

Verified SHC Patient

She is a wonderful and caring physician. Very friendly and is very good at explaining everything.

Feb 2023

•

Verified SHC Patient

I was very pleased overall with my visit with Dr. Hayden

Jan 2023

•

Verified SHC Patient

The visit went well, she explained everything that needed to be discussed and gave ample time for questions.

Jan 2023

•

Verified SHC Patient

She saved my life

Dec 2022

•

Verified SHC Patient

very friendly willing to listen to anything. The best

Dec 2022

•

Verified SHC Patient

An outstanding dr, caring, competent. Has a staff of good drs & nurses who reflect her and Stanford's high standards

Dec 2022

•

Verified SHC Patient

Thank you for your advice and care.

Dec 2022

•

Verified SHC Patient

She is an awesome neurosurgeon. I am very grateful to be her patient.

Nov 2022

•

Verified SHC Patient

Team were all very professional and caring. Answered all questions

Oct 2022

•

Verified SHC Patient

Excellent, patient, caring. Great explanations of options and next steps.

Oct 2022

•

Verified SHC Patient

Dr. Gephart is terrific. Sheâ€™s always a pleasure to talk to and very thorough. I never feel rushed and I appreciate her time.

Oct 2022

•

Verified SHC Patient

I would like to thanks Dr Hayden, teams, and the staffs bared with me to find solutions and the best treatments for my situation . Once again, i would like to thanks and appreciate Dr Hayden, teams, and the staffs for all their effort to care and guide me through during my difficult time

Oct 2022

•

Verified SHC Patient

SHE IS A GREAT DOCTOR.!!! TOO SAD I COULD HAVE A VISUAL COMMUNICATION.

Oct 2022

•

Verified SHC Patient

Dr Hayden is an incredible provider. She is caring competent and I believe excellent in her field. She has my trust.

Aug 2022

•

Verified SHC Patient

Excelente care, explaining of things, made a plan.

Aug 2022

•

Verified SHC Patient

Dr. Hayden is extremely professional and friendly. I appreciate very much for this appointment and her opinions.

Aug 2022

•

Verified SHC Patient

Dr. Hayden was wonderful, attentive as well as her staff. She explained everything in detail and was very reassuring.

Jul 2022

•

Verified SHC Patient

She is wonderful and caring. She is an excellent doctor.

Jul 2022

•

Verified SHC Patient

Excellent physician and very thorough and competent, with a very caring and kind manner. No one wants to be diagnosed with cancer, but if you are, Dr. Hayden is the specialist neuro-oncologist I want in my corner!

Jul 2022

•

Verified SHC Patient

Outstanding service

Jul 2022

•

Verified SHC Patient

Sheâ€™s extremely knowledgeable, kind, and helpful.

Jun 2022

•

Verified SHC Patient

Dr.Hayden is awesome

Jun 2022

•

Verified SHC Patient

Great doctor, very nice and compassionate and concerned. I would highly recommend her.

Jun 2022

•

Verified SHC Patient

Dr Hayden and her team took the time to listen, explain and answer my questions.

Jun 2022

•

Verified SHC Patient

Dr Hayden WAS/is very kind, present, and honest with me. Its such a hard diagnosis to receive, GBM, but i felt she cares. She was an excellent surgeon for me. Im grateful i was referred to her.

Jun 2022

•

Verified SHC Patient

Sheâ€™s fantastic snd always makes me feel good after I visit with her. A calming effect

Jun 2022

•

Verified SHC Patient

I consider myslef priviledged to have a Dr of Dr Hayden's calibre to perform the surgery and follow up with her knowledge and understanding of the procedure and answer all questions that I had that were of a concern to me about the way forward. Dr Hayden was very reassuring and understanding of my concerns and fears fo what lay ahead for me.

Jun 2022

•

Verified SHC Patient

Melanie Hayden Gephart is a talented and amazing Doctor!!

May 2022

•

Verified SHC Patient

My visit was very informative. Dr Hayden and her staff are friendly welcoming and so so knowledgeable

May 2022

•

Verified SHC Patient

Very informative and very nice ðŸ˜Š

May 2022

•

Verified SHC Patient

Dr Hayden is a very concerned physician with her patient like me. Sheâ€™s sincere on what she does professionally. Thank you.

Apr 2022

•

Verified SHC Patient

Thank you Dr. Hayden .you were very understanding and very patience and you took the time to lesson to me .thank you.

Apr 2022

•

Verified SHC Patient

Her understanding and willingness to go into detail about proposed treatment, and reasons for it, always make me feel reassured about future success when dealing with a life-threatening disease.

Apr 2022

•

Verified SHC Patient

Outstanding Dr and staff

Apr 2022

•

Verified SHC Patient

She does wonderful surgery

Mar 2022

•

Verified SHC Patient

Very good information given

Mar 2022

•

Verified SHC Patient

My family and I would once again like to thanks Dr Hayden and her team for saving my life.

Mar 2022

•

Verified SHC Patient

I always receive excellent service at Stanford

Mar 2022

•

Verified SHC Patient

Great Doctor. Looking forward to seeing her.

Feb 2022

•

Verified SHC Patient

She is caring, informative, and comforting.

Feb 2022

•

Verified SHC Patient

I am very happy with Dr Hayden. She is caring, very clear in answering my questions. She is very bright and for me made a wise decision to get me into the hospital through the emergency room and schedule surgery quickly! Iâ€™m grateful for her care.

Feb 2022

•

Verified SHC Patient

Doctor was very informative as well as staff.

Feb 2022

•

Verified SHC Patient

She is amazing brave doctor

Feb 2022

•

Verified SHC Patient

Thank you to her and Rheena for their time and assistance.

Feb 2022

•

Verified SHC Patient

An extremely helpful, professional, approach to patient issues.

Feb 2022

•

Verified SHC Patient

An excellent doctor

Jan 2022

•

Verified SHC Patient

Dr Hayden is the best doctor ever! Dr Hayden is so kind and compassionate and takes the time to explain to the patient the medical condition and the medical plan for future care. She is quite an asset to Stanford and all the patients who seek her help. God bless Dr Hayden with excellent health so she may continue to care for many, many patients who seek medical help.

Jan 2022

•

Verified SHC Patient

Sheâ€™s very professional, nice, thorough and smart. Iâ€™m happy sheâ€™s working with me. I trust her.

Jan 2022

•

Verified SHC Patient

Very clear conversation

Jan 2022

•

Verified SHC Patient

I am so grateful for her <3

Jan 2022

•

Verified SHC Patient

BEST OF ALL

Dec 2021

•

Verified SHC Patient

Excellent Doctor, professional and caring

Dec 2021

•

Verified SHC Patient

She is great!

Nov 2021

•

Verified SHC Patient

Most excellent. I've had no problems with any aspect of my surgery.

Nov 2021

•

Verified SHC Patient

Doctor Melanie Hayden Gephart has been an important team member in my husbands health. She explains terms clearly and with candidly about my husband's diagnosis and treatment or surgical possibilities. She is thorough in reviewing the MRI's and explaining what she sees on the images. Her staff is also thorough in checking for any changes in health or medications. We appreciate her input and expertise along with her staff.

Oct 2021

•

Verified SHC Patient

She and her team are most excellent. The anesthesiologist took me up to the "Star Trek" like operating room and had me breathe in some "oxygen" in a mask and the next thing I was waking up in the recovery room not sure that the operation had yet occurred until I tried to move and felt the sutures on my head. I have experienced no nausea or pain from the operation. The most pain I experienced was like individual hairs being pulled out occasionally when the metal Staples being removed. The removal of tape holding my various intravenous needles in place was much worse but not unexpected because my arms are hairy. Nothing but praise for Dr Gephart and her operating team and the hospital staff and RNs that dealt with me during my stay.

Oct 2021

•

Verified SHC Patient

Doctor Hayden is a great Doctor very knowledgeable and understands each patients condition and concern

Oct 2021

•

Verified SHC Patient

GREAT PERSON TO WORK WITH.

Oct 2021

•

Verified SHC Patient

Superior communicator! Explains complex medical information in a way I can understand

Sep 2021

•

Verified SHC Patient

Dr. Melanie Hayden Gephart is amazing and is extremely personable. She is patient and explains every step in the process in detail and is always checking back to see if I understand what she is explaining. I feel like she takes the time to really listen and understand what I am describing as far as my symptoms or experiences and does not dismiss anything I share. I feel completely safe in her care and would without hesitation recommend Dr. Hayden to anyone that may need her specialty services. I am very fortunate to be a patient of hers and hope to be in her care throughout my cancer journey. Thank you!

Sep 2021

•

Verified SHC Patient

She was great throughout the process of surgery

Aug 2021

•

Verified SHC Patient

Great service

Aug 2021

•

Verified SHC Patient

Doctor Hayden is a good doctor. She care her patient and always answer any question that patient wants to know relate with her treatment. I give her five starts if someone ask me about Doctor Hayden.

Jul 2021

•

Verified SHC Patient

Perfect

Jul 2021

•

Verified SHC Patient

Dr. Melanie Hayden Gephart possesses all the qualities expected, and appreciated, from a world class Neurologist and surgeon, including the bedside manner to put patients as ease.

Jul 2021

•

Verified SHC Patient

Dr Gephart and her team have been awesome to work with. Very responsive each time I went through my portal for appointments or questions. Really has been a pleasure.

Jun 2021

•

Verified SHC Patient

Excellent Neurosurgeon I really appreciate her advice and guidance Thanks a lot

Jun 2021

•

Verified SHC Patient

Very good.

May 2021

•

Verified SHC Patient

We greatly appreciate the time she spends with us. We NEVER feel rushed, and she always ensures all our questions and concerns are addressed.

May 2021

•

Verified SHC Patient

Dr. Hayden is one of my favorite physicians, because she is so attentive!!

Apr 2021

•

Verified SHC Patient

I would like to thanks Dr Hayden and her team really put their effort into my treatments.

Apr 2021

•

Verified SHC Patient

She showed me my MRI and what she was concerned about and explained it very well. I fully understood what she was talking about.

Apr 2021

•

Verified SHC Patient

I am very grateful for Doctor Melanie Hayden expertise. She has been very personable since the first time we were recommended to her and have felt that my care was in the best hands possible at your facility. My deepest and most sincere appreciation to Dr. Hayden and her team!!!

Apr 2021

•

Verified SHC Patient

Phenomenal professionalism and very kind & honest care given by a nurse and a doctor.

Apr 2021

•

Verified SHC Patient

I can't thank you enough. Thank you! Thank You!! Thank YOU!!!

Apr 2021

•

Verified SHC Patient

Dr. Hayden was awesome. Eased my concerns right away.

Dec 2020

•

Verified SHC Patient

I never felt rushed. She really listens and hears what our concerns are. I am grateful I'm in her care - it makes me feel good.

May 2020

•

Verified SHC Patient

Dr. M. Hayden - excellent physician!

Jan 2020

•

Verified SHC Patient

Always a great experience seeing Dr. Hayden she's a wonderful doctor!!

Dec 2019

•

Verified SHC Patient

Dr. Hayden is simply the best!

Nov 2019

•

Verified SHC Patient

One of the best doctor out there!

Oct 2019

•

Verified SHC Patient

Best doctor (Dr. Hayden), best support care!

Oct 2019

•

Verified SHC Patient

I've had 7 brain surgeries. Dr. Hayden is the best I've encountered.

Oct 2019

•

Verified SHC Patient

Dr. Hayden is amazing!

Sep 2019

•

Verified SHC Patient

Needed more follow-up answers.

Aug 2019

•

Verified SHC Patient

Excellent when going into details that I can understand.

Aug 2019

•

Verified SHC Patient

Outstanding, knowledge, attitude, time and overall perspective.

Dec 2018

•

Verified SHC Patient

Very impressed with dr.

Nov 2018

•

Verified SHC Patient

Felt impersonal toward me.

Sep 2018

•

Verified SHC Patient

Dr.Hayden was great and even helped with other pain problems I have.

Sep 2018

•

Verified SHC Patient

Everything was fine.

Jul 2018

•

Verified SHC Patient

All good!

Jun 2018

•

Verified SHC Patient

Excellent, excellent and excellent. First doctor to treat me like a human. Resident also very thorough & kind.

May 2018

•

Verified SHC Patient

Dr. Hayden is wonderful - ALWAYS!!

Mar 2018

•

Verified SHC Patient

Dr. Hayden Gephart as well as the first doctor I met with were both very reassuring and took the time to explain everything.

Jan 2018

•

Verified SHC Patient

Dr. Hayden was an amazing doctor. Only wish they were all like her!

Oct 2017

•

Verified SHC Patient

Dr. Hayden took the time to show me my MRI on the computer and was so helpful & informative. I had so many questions about my diagnosis & she answered them all.

Aug 2017

•

Verified SHC Patient

I have the utmost confidence in Dr. Hayden. She is an exceptional doctor.

Jul 2017

•

Verified SHC Patient

Dr. Hayden is wonderful.

Jun 2017

•

Verified SHC Patient

Great doctor and great people all around.

May 2017

•

Verified SHC Patient

Dr. Hayden is one of the most compassionate doctors I have seen. She LISTENS and provides answers.

May 2017

•

Verified SHC Patient

Well I have never had a bad nor good experience.

Jan 2017

•

Verified SHC Patient

Definitely - amazing physician and woman.

Dec 2016

•

Verified SHC Patient

I simply cannot thank Dr. Melanie Hayden enough for the care I received. Learning about my right frontal lobe tumor diagnosis was hard enough. Knowing how competent and friendly Dr. Melanie Hayden was, eased by fear.

Nov 2016

•

Verified SHC Patient

Outstanding!

Oct 2016

•

Verified SHC Patient

Very good.

Sep 2016

•

Verified SHC Patient

She was amazing. Very nice and helpful.

Jun 2016

•

Verified SHC Patient

Amazing woman! She is cheerful and up beat but also straight forward... Tells it as it is. The operation she performed n me was so successful I walked out of the hospital in two days (spent 2 nights)!

May 2016

•

Verified SHC Patient

I tell all my friends, families, co workers, administration, office people. Love you all.

May 2016

•

Verified SHC Patient

Everyone I seem was caring, and professional.

Apr 2016

•

Verified SHC Patient

Dr. Hayden went over and beyond care that we expected.

Mar 2016

•

Verified SHC Patient

Dr. Hayden is outstanding in every respect.

Mar 2016

•

Verified SHC Patient

Dr. Hayden is very warm and understanding. She's also straight forward & clear in talking abut my conditions. I feel I can trust her. I really like her. Her nurse Michelle is also great. Return calls promptly, very responsive & helpful.

Feb 2016

•

Verified SHC Patient

A very positive experience.

Feb 2016

•

Verified SHC Patient

Always satisfied when I left the office.

Nov 2015

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

Acoustic Neuroma (Vestibular Schwannoma)

Advanced Solid Tumors

Brain Metastases

Brain Tumors

Cancer

Cancer Cell Biology

Cancer Surgery

Cavernous Malformation

Central nervous system tumors

Cranial base surgery

Cranial Nerve Schwannomas

CyberKnife Stereotactic Radiosurgery

Glioblastoma

Glioma

Keyhole Surgery

Laser Interstitial Thermal Therapy

Leptomeningeal Metastases

Meningioma

Meningioma of the Skull Base

Neurological Surgery

Neurosurgical Oncology

Primary Brain Cancer

Radiation for Brain Tumors

Radiosurgery

Skull Base Surgery

Skull Base Tumors

Surgery for Acoustic Neuroma

Surgery for Brain Tumors

Surgery for Glioma, Glioblastoma, & Astrocytoma

Surgery for Meningioma

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Melanie Hayden Gephart

Neurosurgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Neuroscience Health Center

Brain Tumor Center at the Advanced Medicine Center, Clinic D Palo Alto, CA

Brain Tumor Center at the Advanced Medicine Center, Clinic D

CyberKnife Program at the Neuroscience Health Center Palo Alto, CA

CyberKnife Program at the Neuroscience Health Center

Skull Base Surgery at the Neuroscience Health Center Palo Alto, CA

Skull Base Surgery at the Neuroscience Health Center

Stanford Neuroscience Health Center Palo Alto, CA

Stanford Neuroscience Health Center

Pituitary Center Palo Alto, CA

Pituitary Center

Neurosurgery Program Palo Alto, CA

Neurosurgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(160 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Melanie Hayden Gephart

Neurosurgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Neuroscience Health Center

Brain Tumor Center at the Advanced Medicine Center, Clinic D Palo Alto, CA

Brain Tumor Center at the Advanced Medicine Center, Clinic D

CyberKnife Program at the Neuroscience Health Center Palo Alto, CA

CyberKnife Program at the Neuroscience Health Center

Skull Base Surgery at the Neuroscience Health Center Palo Alto, CA

Skull Base Surgery at the Neuroscience Health Center

Stanford Neuroscience Health Center Palo Alto, CA

Stanford Neuroscience Health Center

Pituitary Center Palo Alto, CA

Pituitary Center

Neurosurgery Program Palo Alto, CA

Neurosurgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(160 reviews)

Referring Physicians

PHYSICIAN HELPLINE